Dow Down 0.14% Nasdaq Down 0.27%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
7.51 Down 0.07(0.92%) 2:05PM EDT - Nasdaq Real Time Price
Prev Close:7.58
Open:7.56
Bid:7.50 x 15200
Ask:7.51 x 2100
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:7.50 - 7.61
52wk Range:7.38 - 10.26
Volume:893,485
Avg Vol (3m):2,910,430
Market Cap:1.21B
P/E (ttm):4.54
EPS (ttm):1.65
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIDown 0.92%1.21B
AMGNUp 0.19%106.60B
SGENDown 3.86%4.56B
XOMADown 0.23%456.15M

Key Statistics

Forward P/E (1 yr):3.10
P/S (ttm):2.77
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback